Correlation of Toxins With Gastrointestinal (GI) and Overall Health
NCT ID: NCT06278311
Last Updated: 2024-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
250 participants
OBSERVATIONAL
2025-02-28
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Standardizing Method and Development of Normal Values to Measure Human Small Intestinal and Colonic Permeability
NCT04262310
Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy
NCT04032353
Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
NCT06610760
Contrast-enhanced Multispectral Optoacoustic Tomography for Functional Assessment of the Gastrointestinal Transit
NCT05933096
The Effect of PPI Therapy on Weight, Gut Microbiome, and Expression of GPR41 and GPR43
NCT02457104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
This group will include individuals presenting with digestive and/or non-digestive symptoms or conditions and whose medical evaluation necessitates 'toxin assessment.'
No interventions assigned to this group
Healthy controls
This group will include individuals not presenting with digestive and/or non-digestive symptoms or conditions and who volunteer to provide urine samples for 'toxin assessment.'
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients willing to provide urine samples
* Patients willing to provide consent
Exclusion Criteria
* Patients unwilling to consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Los Angeles Integrative Gastroenterology and Nutrition, Inc
UNKNOWN
Vibrant America Clinical Lab
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Farshid S Rahbar, MD
Role: PRINCIPAL_INVESTIGATOR
Los Angeles Integrative Gastroenterology and Nutrition, Inc
Hari K Krishnamurthy, MS
Role: PRINCIPAL_INVESTIGATOR
Vibrant America Clinical Lab
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Los Angeles Integrative Gastroenterology and Nutrition, Inc
Los Angeles, California, United States
Vibrant America Clinical Lab
Santa Clara, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20235761
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.